A Feasibility Study on the Value of Pelvic Floor Training After Pelvic Organ Prolapse Surgery
Launched by LANDSPITALI UNIVERSITY HOSPITAL · Aug 31, 2020
Trial Information
Current as of June 04, 2025
Unknown status
Keywords
ClinConnect Summary
A feasibility study to assess the practicality of physiotherapy treatment after pelvic organ prolapse (POP) surgery and the effect on recurrent POP symptoms, pelvic floor activity and general physical fitness.
Pelvic organ prolapse is a common problem among women and many do need surgery. Little is known about recurrence of POP surgeries. Pelvic floor muscle training (PFMT) has positive effects on POP symptoms and quality of life. Research shows PFMT can reduce stage of the prolapse.
Before surgery POP-Q stage will be measured by urogynocologist. Pelvic floor muscle activity will be measu...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women having their first POP surgery at LSH
- • \<80 years old
- • Icelandic speaking
- Exclusion Criteria:
- • Women that previously have had incontinence surgery, hysterectomy or previous POP surgery.
- • Dementia, physical disabilities that could affect the research, previous radiotherapy and neurological diseases.
- • Women participating in the research that need to have recurrent POP surgery or incontinence surgery within the year of the surgery.
About Landspitali University Hospital
Landspítali University Hospital is a leading medical institution in Iceland dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates academic excellence with patient care, fostering collaborations among healthcare professionals, researchers, and academic institutions. Its commitment to improving patient outcomes is reflected in its rigorous adherence to ethical standards and regulatory compliance. Landspítali University Hospital aims to contribute to the global medical community by exploring new therapies and treatment modalities, ultimately enhancing the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reykjavík, , Iceland
Patients applied
Trial Officials
Þorgerður Sigurðardóttir, MSc
Principal Investigator
Landspítali University Hospital/University of Iceland, Reykjavík, Iceland.
Helga Medek, MD, MSc
Study Chair
Landspítali University Hospital/University of Iceland, Reykjavík, Iceland.
Þórarinn Sveinsson, PhD
Study Chair
University of Iceland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials